These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 17471601)
1. Guidelines for submitting adverse event reports for publication. Kelly WN; Arellano FM; Barnes J; Bergman U; Edwards IR; Fernandez AM; Freedman SB; Goldsmith DI; Huang K; Jones JK; McLeay R; Moore N; Stather RH; Trenque T; Troutman WG; van Puijenbroek E; Williams F; Wise RP; ; Pharmacoepidemiol Drug Saf; 2007 May; 16(5):581-7. PubMed ID: 17471601 [TBL] [Abstract][Full Text] [Related]
2. Guidelines for submitting adverse event reports for publication. Kelly W; Arellano F; Barnes J; Bergman U; Edwards R; Fernandez A; Freedman S; Goldsmith D; Huang K; Jones J; McLeay R; Moore N; Stather R; Trenque T; Troutman W; van Puijenbroek E; Williams F; Wise R; ; Therapie; 2009; 64(4):289-94. PubMed ID: 19804709 [TBL] [Abstract][Full Text] [Related]
3. Guidelines for submitting adverse event reports for publication. Kelly WN; Arellano FM; Barnes J; Bergman U; Edwards RI; Fernandez AM; Freedman SB; Goldsmith DI; Huang KA; Jones JK; McLeay R; Moore N; Stather RH; Trenque T; Troutman WG; van Puijenbroek E; Williams F; Wise RP; ; Drug Saf; 2007; 30(5):367-73. PubMed ID: 17472416 [TBL] [Abstract][Full Text] [Related]
4. Completeness of published case reports on suspected adverse drug reactions: evaluation of 100 reports from a company safety database. Impicciatore P; Mucci M Drug Saf; 2010 Sep; 33(9):765-73. PubMed ID: 20701409 [TBL] [Abstract][Full Text] [Related]
5. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Wysowski DK; Swartz L Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284 [TBL] [Abstract][Full Text] [Related]
7. [Adverse drug reactions following immunization in Germany pursuant to the German Infection Protection Act and the German Medicinal Products Act from January 1, 2004 to December 31, 2005]. Weisser K; Meyer C; Petzold D; Mentzer D; Keller-Stanislawski B Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Nov; 50(11):1404-17. PubMed ID: 17999134 [TBL] [Abstract][Full Text] [Related]
8. The quality of published adverse drug event reports. Kelly WN Ann Pharmacother; 2003 Dec; 37(12):1774-8. PubMed ID: 14632590 [TBL] [Abstract][Full Text] [Related]
9. Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014. Moore TJ; Furberg CD; Mattison DR; Cohen MR Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):713-8. PubMed ID: 26861066 [TBL] [Abstract][Full Text] [Related]
10. Filling quality of the reports of adverse drug reactions received at the Pharmacovigilance Centre of São Paulo (Brazil): missing information hinders the analysis of suspected associations. Ribeiro A; Lima S; Zampieri ME; Peinado M; Figueras A Expert Opin Drug Saf; 2017 Dec; 16(12):1329-1334. PubMed ID: 28817316 [TBL] [Abstract][Full Text] [Related]
11. [Impact of the spanish pharmacovigilance system recommendations on the publication of cases of adverse drug reaction]. Esteban Calvo C; Ibáñez Ruiz C; Salgueiro Vázquez E; Manso Rodríguez G Aten Primaria; 2008 Nov; 40(11):555-8. PubMed ID: 19055896 [TBL] [Abstract][Full Text] [Related]
12. Toward standardized reporting of drug interactions: the READI checklist for anecdotal reports. Aronson JK Expert Rev Clin Pharmacol; 2015; 8(4):399-409. PubMed ID: 26018632 [TBL] [Abstract][Full Text] [Related]
13. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report. McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291 [TBL] [Abstract][Full Text] [Related]
14. Pharmacoepidemiology and its input to pharmacovigilance. Faillie JL; Montastruc F; Montastruc JL; Pariente A Therapie; 2016 Apr; 71(2):211-6. PubMed ID: 27080840 [TBL] [Abstract][Full Text] [Related]
15. Surveillance of suspected adverse reactions to natural health products in Italy. Menniti-Ippolito F; Mazzanti G; Santuccio C; Moro PA; Calapai G; Firenzuoli F; Valeri A; Raschetti R Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):626-35. PubMed ID: 18327867 [TBL] [Abstract][Full Text] [Related]
16. Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network. Cederholm S; Hill G; Asiimwe A; Bate A; Bhayat F; Persson Brobert G; Bergvall T; Ansell D; Star K; Norén GN Drug Saf; 2015 Jan; 38(1):87-100. PubMed ID: 25539877 [TBL] [Abstract][Full Text] [Related]
17. Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries. Pratt N; Chan EW; Choi NK; Kimura M; Kimura T; Kubota K; Lai EC; Man KK; Ooba N; Park BJ; Sato T; Shin JY; Wong IC; Kao Yang YH; Roughead EE Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):858-64. PubMed ID: 25907076 [TBL] [Abstract][Full Text] [Related]
19. Quality of case reports of adverse drug reactions with psychotropic drugs: a 25-year review. Talat B; Mayers A; Baldwin DS Hum Psychopharmacol; 2013 Sep; 28(5):413-20. PubMed ID: 23754771 [TBL] [Abstract][Full Text] [Related]
20. Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration. Brajovic S; Piazza-Hepp T; Swartz L; Dal Pan G Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):565-70; discussion 571-2. PubMed ID: 22359404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]